まとめ
重量の出産薬にさらされた新生児は,注意力低下を示した. 出産中に軽量な薬を服用した乳児は,最初の数日間,より覚醒した乳児であった.
科学分野:
- 新生児に関する研究.
- 発達心理学の心理学について
- 産科医学は産科医学である.
背景:
- 出産中に母親が服用する薬は,新生児の結果に影響を及ぼす可能性があります.
- 幼児の神経行動反応の評価は,幼児の早期発達を理解する上で極めて重要です.
研究 の 目的:
- 出産中の母親の薬剤投与量と乳児の注意力との関連を調査する.
- 重量の母親用医薬品と軽量の母親用医薬品に曝された新生児の神経行動状態を比較するために.
主な方法:
- 新生児 (2〜4日) の2グループを比較した観察研究.
- 母親は,出産中に受け取った薬の量 (重量対軽量) に基づいて分類されました.
- 幼児の注意力は,標準化された観察方法を使用して評価されました.
主要な成果:
- 母親が重度な出産薬を服用した新生児は,注意力が著しく低下した.
- 軽量な薬を服用した母親から生まれた乳児は,高いレベルの警戒心と反応力を示した.
- 薬剤と注意力の間には,用量依存の関係がある可能性があります.
結論:
- 妊婦が分娩中に多量の薬を服用することは,新生児の注意力の低下と関連しています.
- 出産中の薬を最小限に抑えることは,幼児の神経行動的発達を最適に早期にサポートする可能性があります.
- 長期的な効果や特定のメカニズムを探るため,さらなる研究が必要である.
キーワード:
アルファプロディネ (Alphaprodine) とは鎮痛剤と抗炎症剤注意:注意を向ける幼児,新生児,新生児のことです.労働力 労働力とはMEPERIDINEINE (ミペリディネ) とは - コトバンクペントバルビタール (PENTOBARBITAL) とは ペントバルビタール (PENTOBARBITAL) とは ペントバルビタール (PENTOBARBITAL) とは ペントバルビタール (PENTOBARBITAL) とは薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは,薬理学 (Pharmacology) とは妊娠についてです.プロメタジンはプロメタジンの毒理学レポート視覚的知覚 視覚的な知覚さらに関連する動画
09:43The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
関連する概念動画
Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
